• Consensus Rating: Moderate Buy
  • Consensus Price Target: $7.67
  • Forecasted Upside: 421.54%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$1.47
▼ -0.01 (-0.68%)

This chart shows the closing price for CUTR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cutera Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CUTR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CUTR

Analyst Price Target is $7.67
▲ +421.54% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Cutera in the last 3 months. The average price target is $7.67, with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 421.54% upside from the last price of $1.47.

This chart shows the closing price for CUTR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 4 contributing investment analysts is to moderate buy stock in Cutera. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/21/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/21/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/20/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/18/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/16/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/15/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/14/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/14/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/25/2024StephensReiterated RatingOverweight ➝ Overweight$10.00 ➝ $10.00Low
6/21/2024Piper SandlerReiterated RatingNeutral ➝ Neutral$3.00 ➝ $3.00Low
3/22/2024StephensReiterated RatingOverweight ➝ Overweight$10.00Low
3/22/2024William BlairUpgradeUnderperform ➝ Market PerformLow
3/6/2024StephensReiterated RatingOverweight ➝ Overweight$10.00Low
12/22/2023StephensReiterated RatingOverweight ➝ Overweight$10.00Low
11/9/2023Stifel NicolausLower TargetBuy ➝ Buy$20.00 ➝ $10.00Low
8/9/2023StephensLower Target$42.00 ➝ $33.00Low
7/27/2023Piper SandlerUpgradeUnderweight ➝ Neutral$14.00 ➝ $18.00Low
7/7/2023Stifel NicolausLower Target$35.00 ➝ $24.00Low
5/11/2023William BlairDowngradeOutperform ➝ Market PerformLow
5/10/2023Cantor FitzgeraldLower Target$33.00 ➝ $21.00Low
5/10/2023Piper SandlerInitiated CoverageUnderweight ➝ Underweight$14.00Low
4/14/2023StephensReiterated RatingOverweight$46.00Low
3/30/2023Maxim GroupDowngradeBuy ➝ HoldLow
3/1/2023Maxim GroupLower Target$55.00 ➝ $50.00Low
1/31/2023William BlairInitiated CoverageMarket PerformLow
1/12/2023Maxim GroupLower TargetBuy$80.00 ➝ $55.00Low
1/11/2023Cantor FitzgeraldDowngradeOverweight ➝ Neutral$85.00 ➝ $33.00Low
12/28/2022StephensLower TargetOverweight$78.00 ➝ $68.00Low
10/13/2022StephensInitiated CoverageOverweight$78.00Low
8/5/2022Maxim GroupReiterated RatingBuy$80.00Low
8/5/2022Piper SandlerLower TargetOverweight$65.00 ➝ $55.00Low
5/9/2022StephensBoost Target$68.00 ➝ $78.00High
5/5/2022Maxim GroupBoost Target$60.00 ➝ $80.00Medium
3/28/2022Stifel NicolausBoost Target$60.00 ➝ $70.00High
11/4/2021Maxim GroupUpgradeHold ➝ Buy$60.00High
8/5/2021Piper SandlerBoost TargetOverweight$42.00 ➝ $65.00High
7/13/2021Cantor FitzgeraldBoost TargetOverweight$55.00 ➝ $60.00Low
6/2/2021Cantor FitzgeraldInitiated CoverageOverweight$55.00High
3/5/2021Piper SandlerBoost TargetOverweight$38.00 ➝ $42.00High
2/18/2021Piper SandlerBoost TargetOverweight$28.00 ➝ $38.00High
11/5/2020Piper SandlerBoost TargetOverweight$22.00 ➝ $28.00High
9/30/2020Piper SandlerBoost TargetOverweight$18.00 ➝ $22.00High
9/14/2020StephensBoost TargetOverweight$18.00 ➝ $24.00High
5/8/2020Maxim GroupReiterated RatingHoldLow
5/5/2020Stifel NicolausUpgradeHold ➝ Buy$32.00 ➝ $26.00High
4/22/2020Piper SandlerInitiated CoverageOverweight$18.00Low
3/23/2020StephensLower TargetOverweight$45.00 ➝ $15.00High
2/28/2020Maxim GroupReiterated RatingHoldMedium
11/8/2019StephensBoost TargetOverweight$35.00 ➝ $45.00High
8/22/2019SidotiDowngradeBuy ➝ NeutralHigh
8/9/2019Maxim GroupReiterated RatingHoldLow
(Data available from 7/15/2019 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/17/2023
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/16/2024
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/15/2024
  • 3 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
3/16/2024
  • 1 very positive mentions
  • 11 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
4/15/2024
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/15/2024
  • 1 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/14/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/14/2024

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Cutera logo
Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all body and skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and enlighten, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides excel HR, a hair removal solution for all skin types; and xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.
Read More

Today's Range

Now: $1.47
Low: $1.46
High: $1.59

50 Day Range

MA: $1.89
Low: $1.28
High: $2.86

52 Week Range

Now: $1.47
Low: $1.28
High: $21.41

Volume

491,500 shs

Average Volume

1,246,917 shs

Market Capitalization

$29.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32

Frequently Asked Questions

What sell-side analysts currently cover shares of Cutera?

The following sell-side analysts have issued stock ratings on Cutera in the last twelve months: Piper Sandler, Stephens, Stifel Nicolaus, StockNews.com, and William Blair.
View the latest analyst ratings for CUTR.

What is the current price target for Cutera?

3 Wall Street analysts have set twelve-month price targets for Cutera in the last year. Their average twelve-month price target is $7.67, suggesting a possible upside of 421.5%. Stifel Nicolaus has the highest price target set, predicting CUTR will reach $10.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $3.00 for Cutera in the next year.
View the latest price targets for CUTR.

What is the current consensus analyst rating for Cutera?

Cutera currently has 2 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for CUTR.

What other companies compete with Cutera?

How do I contact Cutera's investor relations team?

Cutera's physical mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The medical device company's listed phone number is (415) 657-5500 and its investor relations email address is [email protected]. The official website for Cutera is www.cutera.com. Learn More about contacing Cutera investor relations.